anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Centessa Pharmaceuticals · pitchdeck

Centessa | IPO Presentation Deck | 33 slides

33 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Centessa | IPO Presentation Deck | 33 slides

Centessa Pharmaceuticals · 2021-05
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 16 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 5 slides 100% 5/5 slides 100% 5/5 slides · 20 hits
— 0/5 slides
40% 2/5 slides 20% 1/5 slides 100% 5/5 slides · 6 hits
— 0/5 slides
Solution 5 slides 100% 5/5 slides 100% 5/5 slides · 13 hits
— 0/5 slides
20% 1/5 slides 60% 3/5 slides 100% 5/5 slides 100% 5/5 slides Market Size 5 slides 100% 5/5 slides 100% 5/5 slides · 25 hits
— 0/5 slides
60% 3/5 slides · 4 hits 40% 2/5 slides 100% 5/5 slides 20% 1/5 slides Team 1 slides 100% 1/1 slides 100% 1/1 slides · 9 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides · 2 hits
— 0/1 slides

Slide inventory

33
every slide · same image gating as the playbook
01
Slide 1
transition
Open slide detailBeat · Problem
02
other
Open slide detailBeat · Problem
03
This is a standard IPO deal terms slide often found in roadshow decks.summarize
Open slide detailBeat · Problem
04
The slide uses a grid layout to present 8 team members, each with a headshot, name, title, and a collection of company logos.other
Open slide detailBeat · Problem
05
The slide uses a hub-and-spoke visual metaphor where five key organizational pillars feed into the central 'Asset Centricity' model.inspire_vision
Open slide detailBeat · Problem
06
The slide uses a side-by-side comparison table to highlight the advantages of the company's model over the traditional single-asset approach.compare_peers
Open slide detailBeat · SolutionLoop · Logic Chain
07
The slide uses a visual timeline to illustrate the history of the constituent companies leading up to the formation of Centessa.establish_context
Open slide detailBeat · SolutionLoop · Logic Chain
08
The chart uses a Gantt-style visualization to show the development stage of multiple drug candidates.plan_implementation
Open slide detailBeat · SolutionLoop · Logic Chain
09
The slide highlights the expertise behind the company's programs by showcasing the founders and key executives alongside their professional backgrounds.other
Open slide detailBeat · SolutionLoop · Logic Chain
10
The slide highlights the connection between specific programs and the deep expertise of the scientists leading them.show_traction
Open slide detailBeat · SolutionLoop · Logic Chain
11
The slide uses a three-column layout to summarize the company's core value proposition.summarize
Open slide detailBeat · Market Size
12
Includes a biological mechanism diagram and a comparative table of clinical/simulated toxicity markers.compare_peers
Open slide detailBeat · Market Size
13
The slide uses a before-after-bridge framing to show drug safety.illustrate_case
Open slide detailBeat · Market Size
14
Includes a time-course line chart of urine osmolality and a bar chart comparing efficacy against Tolvaptan.show_traction
Open slide detailBeat · Market SizeLoop · Cost Of Inaction
15
The slide outlines a two-part study structure involving screening, randomization, a double-blind treatment period, and an open-label maintenance period.plan_implementation
Open slide detailBeat · Market Size
16
The slide uses a split-column layout to contrast internal development milestones with external competitive threats.compare_peers
Open slide detail
17
The slide uses a three-column layout to summarize the company's core value proposition.summarize
Open slide detail
18
The slide uses a biological pathway diagram to illustrate the mechanism of action.present_solution
Open slide detail
19
Includes two distinct experimental results: survival curves and dose-dependent blood loss reduction.show_traction
Open slide detail
20
Includes a process flow diagram for the Phase 1 SAD (Single Ascending Dose) study.show_traction
Open slide detail
21
The slide uses a split-column layout to contrast internal milestones with external competitive landscape.compare_peers
Open slide detail
22
The slide uses a three-column layout to summarize mission, data, and market.summarize
Open slide detail
23
Includes both longitudinal dosing data and endpoint histology/biomarker analysis.analyze_data
Open slide detail
24
The slide uses a split-layout comparing internal development status against external competitive programs.compare_peers
Open slide detail
25
The slide provides a high-level summary of the therapeutic program MGX292.summarize
Open slide detail
26
The slide uses visual evidence (X-rays) to demonstrate a lack of efficacy/activity for the drug candidate MGX292 in an in vivo model.analyze_data
Open slide detail
27
The slide uses a three-stage process diagram to show the progression from normal lung to diseased state and subsequent reversal.show_traction
Open slide detail
28
The slide uses a split-column layout to contrast internal milestones with external competitive intelligence.compare_peers
Open slide detail
29
The slide lists multiple subsidiary programs under the Centessa umbrella, mapping them to specific scientific leads and therapeutic mechanisms.analyze_data
Open slide detail
30
plan_implementation
Open slide detail
31
The table outlines specific clinical programs (ALERT, ACTION, ZF874, ZF877, SerpinPC) associated with the funding allocations.plan_implementation
Open slide detail
32
The slide uses a logo grid for investors and a structured table/list for board members.show_traction
Open slide detail
33
summarize
Open slide detail